4//SEC Filing
Swayze Eric 4
Accession 0000874015-25-000262
CIK 0000874015other
Filed
Oct 15, 8:00 PM ET
Accepted
Oct 16, 8:16 PM ET
Size
9.8 KB
Accession
0000874015-25-000262
Insider Transaction Report
Form 4
Swayze Eric
EVP Research
Transactions
- Exercise/Conversion
Restricted Stock Unit
2025-10-15−125→ 497 total(indirect: by Son)Exercise: $0.00From: 2025-10-15→ Common Stock (125 underlying) - Sale
Common Stock
2025-10-16$73.62/sh−53$3,902→ 256 total(indirect: by Son) - Exercise/Conversion
Common Stock
2025-10-15+125→ 309 total(indirect: by Son)
Holdings
- 30,453
Common Stock
Footnotes (4)
- [F1]Acquired pursuant to vesting and release of shares in accordance with a Restricted Stock Unit award.
- [F2]The sale was made pursuant to an automatic sale to cover the required tax withholding obligations pursuant to the 2011 Equity Incentive Plan Restricted Stock Unit Agreement and Grant Notice.
- [F3]Each Restricted Stock Unit represents a contingent right to receive one share of Ionis common stock, or its equivalent cash value.
- [F4]Restricted Stock Units vest in four equal annual installments. Upon vesting, the restricted stock units will be paid out in whole shares of Ionis common stock or cash as may be determined by the Company.
Documents
Issuer
IONIS PHARMACEUTICALS INC
CIK 0000874015
Entity typeother
Related Parties
1- filerCIK 0001791058
Filing Metadata
- Form type
- 4
- Filed
- Oct 15, 8:00 PM ET
- Accepted
- Oct 16, 8:16 PM ET
- Size
- 9.8 KB